Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Soligenix, Inc.

Equities

SNGX

US8342235053

Delayed Nasdaq
Other stock markets
 20:54:58 03/05/2024 BST 		5-day change 1st Jan Change
0.4 USD -1.11% Intraday chart for Soligenix, Inc. -3.61% -47.17%
04-25 Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa CI
04-15 Sector Update: Health Care Stocks Softer Late Afternoon MT

Evolution of the average Target Price on Soligenix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

655e175232cb36e6e0a3c052.l7LCWpqf-KA2uy2pbC5tKfQXobiq5GNkXJMGWhJGLug.24eXaff7yslX1UfmLmICR79tkP7nlA0yZdBOGHsyVKLvwa0Q0N2Q52z1HQ~b178221f4092e444e0e6f0d4d7982372

Analyst Recommendations on Soligenix, Inc.

SOLIGENIX : Alliance Global Adjusts Price Target on Soligenix to $3.75 From $5.75, Reiterates Buy Rating MT
SOLIGENIX : B. Riley Lowers Soligenix' PT to $1.50 from $2 on Unchanged Valuation Methodology, Keeps Neutral Rating MT
SOLIGENIX : B. Riley Starts Soligenix at Buy With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4045 USD
Average target price
3.5 USD
Spread / Average Target
+765.27%
High Price Target
4 USD
Spread / Highest target
+888.88%
Low Price Target
3 USD
Spread / Lowest Target
+641.66%

Consensus detail

Consensus revision (last 18 months)

Ratings for Soligenix, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Consensus Soligenix, Inc.